CA2012895A1 - Vaccin de cytomegalovirus recombinant - Google Patents

Vaccin de cytomegalovirus recombinant

Info

Publication number
CA2012895A1
CA2012895A1 CA2012895A CA2012895A CA2012895A1 CA 2012895 A1 CA2012895 A1 CA 2012895A1 CA 2012895 A CA2012895 A CA 2012895A CA 2012895 A CA2012895 A CA 2012895A CA 2012895 A1 CA2012895 A1 CA 2012895A1
Authority
CA
Canada
Prior art keywords
cytomegalovirus vaccine
recombinant cytomegalovirus
recombinant
vaccine
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2012895A
Other languages
English (en)
Other versions
CA2012895C (fr
Inventor
Robert P. Ricciardi
Stanley A. Plotkin
Eva Gonczol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2012895A1 publication Critical patent/CA2012895A1/fr
Application granted granted Critical
Publication of CA2012895C publication Critical patent/CA2012895C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002012895A 1989-03-24 1990-03-23 Vaccin de cytomegalovirus recombinant Expired - Fee Related CA2012895C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32840689A 1989-03-24 1989-03-24
US07/328,406 1989-03-24

Publications (2)

Publication Number Publication Date
CA2012895A1 true CA2012895A1 (fr) 1990-09-24
CA2012895C CA2012895C (fr) 2000-01-18

Family

ID=23280848

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002012895A Expired - Fee Related CA2012895C (fr) 1989-03-24 1990-03-23 Vaccin de cytomegalovirus recombinant

Country Status (7)

Country Link
EP (1) EP0389286B1 (fr)
AT (1) ATE140154T1 (fr)
CA (1) CA2012895C (fr)
DE (1) DE69027695T2 (fr)
DK (1) DK0389286T3 (fr)
ES (1) ES2091221T3 (fr)
GR (1) GR3020765T3 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6319716B1 (en) 1997-06-23 2001-11-20 University Of Saskatchewan Bovine adenovirus type 3 genome and vector systems derived therefrom

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
WO1994023744A1 (fr) * 1993-04-16 1994-10-27 The Wistar Institute Of Anatomy And Biology Vaccin contenant un cytomegalovirus de recombinaison
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
CA2410665C (fr) 2000-05-31 2017-11-07 University Of Saskatchewan Adenovirus bovin modifie avec modification du tropisme

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
CA1335429C (fr) * 1986-03-07 1995-05-02 Geoffrey L. Smith Procedes de fabrication de glycoproteines hcmv, les anticorps et les vaccins diriges contre ces glycoproteines hcmv, et leurs vecteurs recombinants
DE3619720A1 (de) * 1986-06-12 1987-12-17 Behringwerke Ag Hauptglykoprotein des menschlichen cytomegalovirus, seine herstellung und verwendung
DE3782867D1 (en) * 1986-06-12 1993-01-14 Behringwerke Ag, 3550 Marburg, De Human cytomegalovirus phospho-protein
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ZA878031B (en) * 1986-11-04 1988-04-28 Scripps Clinic And Research Foundation Nucleic acid probes for the detection of latent human cytomegalovirus in blood products
EP0277773A1 (fr) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Cytomégalovirus hybride et vaccin

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6001591A (en) * 1993-12-09 1999-12-14 University Of Saskatchewan Recombinant bovine adenoviruses
US6086890A (en) * 1993-12-09 2000-07-11 University Of Saskatchewan Bovine adenovirus expression vector system
US6379944B1 (en) 1993-12-09 2002-04-30 University Of Saskatchewan Mammalian cell lines expressing bovine adenovirus functions
US7025967B2 (en) 1993-12-09 2006-04-11 University Of Saskatchewan Recombinant protein production in bovine adenovirus expression vector system
US6319716B1 (en) 1997-06-23 2001-11-20 University Of Saskatchewan Bovine adenovirus type 3 genome and vector systems derived therefrom

Also Published As

Publication number Publication date
EP0389286A3 (fr) 1991-06-12
EP0389286B1 (fr) 1996-07-10
GR3020765T3 (en) 1996-11-30
DE69027695T2 (de) 1997-02-20
ES2091221T3 (es) 1996-11-01
DK0389286T3 (da) 1996-11-18
CA2012895C (fr) 2000-01-18
ATE140154T1 (de) 1996-07-15
DE69027695D1 (de) 1996-08-14
EP0389286A2 (fr) 1990-09-26

Similar Documents

Publication Publication Date Title
NZ517686A (en) Bovine vaccine formula comprising plasmid or plasmids containing gB and gD genes from the bovine herpesvirus
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
EP1712628A3 (fr) Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
AU5457596A (en) Adjuvants for viral vaccines
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
AU1632392A (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
CA2186044A1 (fr) Nouveaux virus mutes, composes antiviraux et nouveaux procedes de production de vaccins
AU5457496A (en) Adjuvants for viral vaccines
CA2012895A1 (fr) Vaccin de cytomegalovirus recombinant
AU4826493A (en) Anti-feline immunodeficiency virus (fiv) vaccines
EP0888777A3 (fr) Polypeptides et vaccins recombinés contre l'herpèsvirus bovin type 1
GB2264949B (en) Measles virus recombinant poxvirus vaccine
EP0366238A3 (fr) Polypeptides vaccinaux d'influenza
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.
EP0560776A4 (en) The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
EP1136562A3 (fr) Vaccins contre le virus de la leucémie féline
GB9818133D0 (en) Vaccine
WO1989010965A3 (fr) Glycoproteine h des virus herpetiques
AU2775692A (en) Recombinant influenza virus vaccine compositions
CA2176929A1 (fr) Vaccin contre les oreillons contenant une souche virale jeryl-lynn
CA2072982A1 (fr) Vaccins contre l'hepatite a
AU4863490A (en) Polypeptides, antigens or vaccines protective against babesiosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed